LYONDELLBASELL INDU-CL A (LYB) Stock Fundamental Analysis

NYSE:LYB • NL0009434992

55.97 USD
-0.01 (-0.02%)
At close: Feb 18, 2026
55.97 USD
0 (0%)
After Hours: 2/18/2026, 4:56:27 PM
Fundamental Rating

3

Overall LYB gets a fundamental rating of 3 out of 10. We evaluated LYB against 83 industry peers in the Chemicals industry. Both the profitability and financial health of LYB have multiple concerns. LYB has a valuation in line with the averages, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

  • LYB had positive earnings in the past year.
  • LYB had a positive operating cash flow in the past year.
  • LYB had positive earnings in 4 of the past 5 years.
  • LYB had a positive operating cash flow in 4 of the past 5 years.
LYB Yearly Net Income VS EBIT VS OCF VS FCFLYB Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B

1.2 Ratios

  • With a Return On Assets value of -3.59%, LYB is not doing good in the industry: 63.86% of the companies in the same industry are doing better.
  • The Return On Equity of LYB (-11.44%) is worse than 66.27% of its industry peers.
  • LYB has a Return On Invested Capital (3.64%) which is in line with its industry peers.
  • LYB had an Average Return On Invested Capital over the past 3 years of 10.69%. This is above the industry average of 6.07%.
  • The last Return On Invested Capital (3.64%) for LYB is well below the 3 year average (10.69%), which needs to be investigated, but indicates that LYB had better years and this may not be a problem.
Industry RankSector Rank
ROA -3.59%
ROE -11.44%
ROIC 3.64%
ROA(3y)6.72%
ROA(5y)7.89%
ROE(3y)19.31%
ROE(5y)24.61%
ROIC(3y)10.69%
ROIC(5y)11.69%
LYB Yearly ROA, ROE, ROICLYB Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 20 40 60

1.3 Margins

  • In the last couple of years the Profit Margin of LYB has declined.
  • LYB has a Operating Margin of 3.65%. This is in the lower half of the industry: LYB underperforms 61.45% of its industry peers.
  • In the last couple of years the Operating Margin of LYB has declined.
  • Looking at the Gross Margin, with a value of 9.19%, LYB is doing worse than 83.13% of the companies in the same industry.
  • LYB's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 3.65%
PM (TTM) N/A
GM 9.19%
OM growth 3Y-24.61%
OM growth 5Y-10.5%
PM growth 3Y-34.85%
PM growth 5Y-19.21%
GM growth 3Y-15.85%
GM growth 5Y-6.35%
LYB Yearly Profit, Operating, Gross MarginsLYB Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15 20

2

2. Health

2.1 Basic Checks

  • LYB has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
  • LYB has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
LYB Yearly Shares OutstandingLYB Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M
LYB Yearly Total Debt VS Total AssetsLYB Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 10B 20B 30B

2.2 Solvency

  • An Altman-Z score of 1.99 indicates that LYB is not a great score, but indicates only limited risk for bankruptcy at the moment.
  • Looking at the Altman-Z score, with a value of 1.99, LYB is in line with its industry, outperforming 53.01% of the companies in the same industry.
  • The Debt to FCF ratio of LYB is 16.07, which is on the high side as it means it would take LYB, 16.07 years of fcf income to pay off all of its debts.
  • LYB has a Debt to FCF ratio of 16.07. This is comparable to the rest of the industry: LYB outperforms 51.81% of its industry peers.
  • A Debt/Equity ratio of 1.02 is on the high side and indicates that LYB has dependencies on debt financing.
  • LYB has a Debt to Equity ratio of 1.02. This is in the lower half of the industry: LYB underperforms 67.47% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.02
Debt/FCF 16.07
Altman-Z 1.99
ROIC/WACC0.46
WACC7.91%
LYB Yearly LT Debt VS Equity VS FCFLYB Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B

2.3 Liquidity

  • LYB has a Current Ratio of 1.57. This is a normal value and indicates that LYB is financially healthy and should not expect problems in meeting its short term obligations.
  • LYB has a worse Current ratio (1.57) than 66.27% of its industry peers.
  • LYB has a Quick Ratio of 1.57. This is a bad value and indicates that LYB is not financially healthy enough and could expect problems in meeting its short term obligations.
  • The Quick ratio of LYB (0.93) is worse than 66.27% of its industry peers.
Industry RankSector Rank
Current Ratio 1.57
Quick Ratio 0.93
LYB Yearly Current Assets VS Current LiabilitesLYB Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B 10B

2

3. Growth

3.1 Past

  • The earnings per share for LYB have decreased strongly by -73.44% in the last year.
  • LYB shows a very negative growth in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -21.44% yearly.
EPS 1Y (TTM)-73.44%
EPS 3Y-48.49%
EPS 5Y-21.44%
EPS Q2Q%-134.67%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-25.33%

3.2 Future

  • Based on estimates for the next years, LYB will show a very strong growth in Earnings Per Share. The EPS will grow by 48.11% on average per year.
  • LYB is expected to show a decrease in Revenue. In the coming years, the Revenue will decrease by -0.68% yearly.
EPS Next Y58.88%
EPS Next 2Y51.34%
EPS Next 3Y45.54%
EPS Next 5Y48.11%
Revenue Next Year-1.4%
Revenue Next 2Y-0.37%
Revenue Next 3Y0.93%
Revenue Next 5Y-0.68%

3.3 Evolution

  • The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
LYB Yearly Revenue VS EstimatesLYB Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 10B 20B 30B 40B 50B
LYB Yearly EPS VS EstimatesLYB Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 5 10 15

4

4. Valuation

4.1 Price/Earnings Ratio

  • The Price/Earnings ratio is 32.92, which means the current valuation is very expensive for LYB.
  • LYB's Price/Earnings ratio is in line with the industry average.
  • LYB's Price/Earnings ratio indicates a valuation a bit more expensive than the S&P500 average which is at 27.16.
  • A Price/Forward Earnings ratio of 20.72 indicates a rather expensive valuation of LYB.
  • LYB's Price/Forward Earnings ratio is in line with the industry average.
  • Compared to an average S&P500 Price/Forward Earnings ratio of 28.10, LYB is valued a bit cheaper.
Industry RankSector Rank
PE 32.92
Fwd PE 20.72
LYB Price Earnings VS Forward Price EarningsLYB Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

  • LYB's Enterprise Value to EBITDA is on the same level as the industry average.
  • Based on the Price/Free Cash Flow ratio, LYB is valued a bit cheaper than the industry average as 67.47% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 24.42
EV/EBITDA 10.83
LYB Per share dataLYB EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 20 40 60 80 100

4.3 Compensation for Growth

  • LYB's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • LYB's earnings are expected to grow with 45.54% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.56
PEG (5Y)N/A
EPS Next 2Y51.34%
EPS Next 3Y45.54%

6

5. Dividend

5.1 Amount

  • With a Yearly Dividend Yield of 9.48%, LYB is a good candidate for dividend investing.
  • LYB's Dividend Yield is rather good when compared to the industry average which is at 2.15. LYB pays more dividend than 93.98% of the companies in the same industry.
  • LYB's Dividend Yield is rather good when compared to the S&P500 average which is at 1.82.
Industry RankSector Rank
Dividend Yield 9.48%

5.2 History

  • The dividend of LYB has a limited annual growth rate of 5.17%.
  • LYB has paid a dividend for at least 10 years, which is a reliable track record.
  • LYB has decreased its dividend recently.
Dividend Growth(5Y)5.17%
Div Incr Years1
Div Non Decr Years1
LYB Yearly Dividends per shareLYB Yearly Dividends per shareYearly Dividends per share 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2 4 6 8

5.3 Sustainability

  • The earnings of LYB are negative and hence is the payout ratio. LYB will probably not be able to sustain this dividend level.
  • LYB's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP-144.93%
EPS Next 2Y51.34%
EPS Next 3Y45.54%
LYB Yearly Income VS Free CF VS DividendLYB Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B 5B

LYONDELLBASELL INDU-CL A

NYSE:LYB (2/18/2026, 4:56:27 PM)

After market: 55.97 0 (0%)

55.97

-0.01 (-0.02%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)01-30
Earnings (Next)04-23
Inst Owners71.84%
Inst Owner Change-0.31%
Ins Owners0.18%
Ins Owner Change0.01%
Market Cap18.02B
Revenue(TTM)N/A
Net Income(TTM)-1.21B
Analysts52.14
Price Target52.08 (-6.95%)
Short Float %8.43%
Short Ratio3.47
Dividend
Industry RankSector Rank
Dividend Yield 9.48%
Yearly Dividend5.31
Dividend Growth(5Y)5.17%
DP-144.93%
Div Incr Years1
Div Non Decr Years1
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)0.36%
Min EPS beat(2)-23.45%
Max EPS beat(2)24.17%
EPS beat(4)2
Avg EPS beat(4)-4.8%
Min EPS beat(4)-23.45%
Max EPS beat(4)24.17%
EPS beat(8)4
Avg EPS beat(8)-1.26%
EPS beat(12)8
Avg EPS beat(12)5.26%
EPS beat(16)10
Avg EPS beat(16)2.78%
Revenue beat(2)2
Avg Revenue beat(2)2.02%
Min Revenue beat(2)0.76%
Max Revenue beat(2)3.27%
Revenue beat(4)4
Avg Revenue beat(4)1.93%
Min Revenue beat(4)0.76%
Max Revenue beat(4)3.27%
Revenue beat(8)6
Avg Revenue beat(8)0.64%
Revenue beat(12)7
Avg Revenue beat(12)-0.64%
Revenue beat(16)10
Avg Revenue beat(16)0.42%
PT rev (1m)0.32%
PT rev (3m)-11.29%
EPS NQ rev (1m)-16.2%
EPS NQ rev (3m)-78.71%
EPS NY rev (1m)-5.49%
EPS NY rev (3m)-12.2%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-1.38%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.19%
Valuation
Industry RankSector Rank
PE 32.92
Fwd PE 20.72
P/S 0.55
P/FCF 24.42
P/OCF 6.75
P/B 1.7
P/tB 1.91
EV/EBITDA 10.83
EPS(TTM)1.7
EY3.04%
EPS(NY)2.7
Fwd EY4.83%
FCF(TTM)2.29
FCFY4.09%
OCF(TTM)8.29
OCFY14.81%
SpS101.11
BVpS32.92
TBVpS29.31
PEG (NY)0.56
PEG (5Y)N/A
Graham Number35.48
Profitability
Industry RankSector Rank
ROA -3.59%
ROE -11.44%
ROCE 4.41%
ROIC 3.64%
ROICexc 3.89%
ROICexgc 4.08%
OM 3.65%
PM (TTM) N/A
GM 9.19%
FCFM 2.27%
ROA(3y)6.72%
ROA(5y)7.89%
ROE(3y)19.31%
ROE(5y)24.61%
ROIC(3y)10.69%
ROIC(5y)11.69%
ROICexc(3y)11.83%
ROICexc(5y)12.68%
ROICexgc(3y)12.95%
ROICexgc(5y)13.92%
ROCE(3y)12.98%
ROCE(5y)14.24%
ROICexgc growth 3Y-25.81%
ROICexgc growth 5Y-9.22%
ROICexc growth 3Y-25.6%
ROICexc growth 5Y-8.64%
OM growth 3Y-24.61%
OM growth 5Y-10.5%
PM growth 3Y-34.85%
PM growth 5Y-19.21%
GM growth 3Y-15.85%
GM growth 5Y-6.35%
F-Score3
Asset Turnover0.96
Health
Industry RankSector Rank
Debt/Equity 1.02
Debt/FCF 16.07
Debt/EBITDA 4.18
Cap/Depr 138.59%
Cap/Sales 5.93%
Interest Coverage 250
Cash Conversion 103.45%
Profit Quality N/A
Current Ratio 1.57
Quick Ratio 0.93
Altman-Z 1.99
F-Score3
WACC7.91%
ROIC/WACC0.46
Cap/Depr(3y)123.27%
Cap/Depr(5y)130.2%
Cap/Sales(3y)4.01%
Cap/Sales(5y)4.66%
Profit Quality(3y)139.02%
Profit Quality(5y)124.38%
High Growth Momentum
Growth
EPS 1Y (TTM)-73.44%
EPS 3Y-48.49%
EPS 5Y-21.44%
EPS Q2Q%-134.67%
EPS Next Y58.88%
EPS Next 2Y51.34%
EPS Next 3Y45.54%
EPS Next 5Y48.11%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-25.33%
Revenue Next Year-1.4%
Revenue Next 2Y-0.37%
Revenue Next 3Y0.93%
Revenue Next 5Y-0.68%
EBIT growth 1Y-60.92%
EBIT growth 3Y-27.96%
EBIT growth 5Y-7.79%
EBIT Next Year-11.44%
EBIT Next 3Y5.64%
EBIT Next 5Y10.29%
FCF growth 1Y-79.05%
FCF growth 3Y-29.85%
FCF growth 5Y-2.67%
OCF growth 1Y-47.04%
OCF growth 3Y-20.83%
OCF growth 5Y-5.1%

LYONDELLBASELL INDU-CL A / LYB FAQ

Can you provide the ChartMill fundamental rating for LYONDELLBASELL INDU-CL A?

ChartMill assigns a fundamental rating of 3 / 10 to LYB.


What is the valuation status of LYONDELLBASELL INDU-CL A (LYB) stock?

ChartMill assigns a valuation rating of 4 / 10 to LYONDELLBASELL INDU-CL A (LYB). This can be considered as Fairly Valued.


How profitable is LYONDELLBASELL INDU-CL A (LYB) stock?

LYONDELLBASELL INDU-CL A (LYB) has a profitability rating of 3 / 10.


How financially healthy is LYONDELLBASELL INDU-CL A?

The financial health rating of LYONDELLBASELL INDU-CL A (LYB) is 2 / 10.


What is the earnings growth outlook for LYONDELLBASELL INDU-CL A?

The Earnings per Share (EPS) of LYONDELLBASELL INDU-CL A (LYB) is expected to grow by 58.88% in the next year.